Gene expression of CCAAT/enhancer-binding protein δ mediated by autoregulation is repressed by related gene family proteins

Atsuhiro Tanabe, Chizumi Kumahara, Shigehiro Osada, Tsutomu Nishihara, Masayoshi Imagawa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

CCAAT/enhancer-binding protein δ (C/EBPδ) transcription factor is rapidly induced at an early stage of acute phase response. We previously reported that this induction was mainly mediated by acute phase response factor/signal transducers and activators of transcription 3 (APRF/STAT3). Furthermore, the high expression level of C/EBPδ is maintained by autoregulation mechanisms through the C/EBPδ binding sites located downstream of C/EBPδ gene. Thereafter, the expression of C/EBPδ gene decreases rapidly to the basal level. However, these mechanisms are still unknown. According to both transfection and DNA binding analyses, liver-enriched inhibitory protein (LIP), the shorter form of C/EBPβ and C/EBP-homologous protein 10 (CHOP10), were found to inhibit C/EBPδ gene expression. DNA binding analysis has further indicated that both LIP and CHOP10 form heterodimers with C/EBPδ, and inhibit the binding of C/EBPδ homodimer to the C/EBPδ binding sites located downstream of C/EBPδ gene. Taken together, these findings indicated that the maintained expression of C/EBPδ gene by autoregulation was inhibited and decreased to the basal level as a result of the competition of other C/EBP family proteins. Thus, C/EBPδ gene expression is mediated by the gene regulation circuit through the downstream C/EBPδ binding sites.

Original languageEnglish
Pages (from-to)1424-1429
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume23
Issue number12
Publication statusPublished - 2000
Externally publishedYes

Keywords

  • Autoregulation
  • CCAAT/enhancer-binding protein
  • CHOP
  • Gene expression
  • Trans-acting factor
  • Transcription

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Gene expression of CCAAT/enhancer-binding protein δ mediated by autoregulation is repressed by related gene family proteins. / Tanabe, Atsuhiro; Kumahara, Chizumi; Osada, Shigehiro; Nishihara, Tsutomu; Imagawa, Masayoshi.

In: Biological and Pharmaceutical Bulletin, Vol. 23, No. 12, 2000, p. 1424-1429.

Research output: Contribution to journalArticle

Tanabe, Atsuhiro ; Kumahara, Chizumi ; Osada, Shigehiro ; Nishihara, Tsutomu ; Imagawa, Masayoshi. / Gene expression of CCAAT/enhancer-binding protein δ mediated by autoregulation is repressed by related gene family proteins. In: Biological and Pharmaceutical Bulletin. 2000 ; Vol. 23, No. 12. pp. 1424-1429.
@article{6a40d15ba7084062aa262135c00b21d0,
title = "Gene expression of CCAAT/enhancer-binding protein δ mediated by autoregulation is repressed by related gene family proteins",
abstract = "CCAAT/enhancer-binding protein δ (C/EBPδ) transcription factor is rapidly induced at an early stage of acute phase response. We previously reported that this induction was mainly mediated by acute phase response factor/signal transducers and activators of transcription 3 (APRF/STAT3). Furthermore, the high expression level of C/EBPδ is maintained by autoregulation mechanisms through the C/EBPδ binding sites located downstream of C/EBPδ gene. Thereafter, the expression of C/EBPδ gene decreases rapidly to the basal level. However, these mechanisms are still unknown. According to both transfection and DNA binding analyses, liver-enriched inhibitory protein (LIP), the shorter form of C/EBPβ and C/EBP-homologous protein 10 (CHOP10), were found to inhibit C/EBPδ gene expression. DNA binding analysis has further indicated that both LIP and CHOP10 form heterodimers with C/EBPδ, and inhibit the binding of C/EBPδ homodimer to the C/EBPδ binding sites located downstream of C/EBPδ gene. Taken together, these findings indicated that the maintained expression of C/EBPδ gene by autoregulation was inhibited and decreased to the basal level as a result of the competition of other C/EBP family proteins. Thus, C/EBPδ gene expression is mediated by the gene regulation circuit through the downstream C/EBPδ binding sites.",
keywords = "Autoregulation, CCAAT/enhancer-binding protein, CHOP, Gene expression, Trans-acting factor, Transcription",
author = "Atsuhiro Tanabe and Chizumi Kumahara and Shigehiro Osada and Tsutomu Nishihara and Masayoshi Imagawa",
year = "2000",
language = "English",
volume = "23",
pages = "1424--1429",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "12",

}

TY - JOUR

T1 - Gene expression of CCAAT/enhancer-binding protein δ mediated by autoregulation is repressed by related gene family proteins

AU - Tanabe, Atsuhiro

AU - Kumahara, Chizumi

AU - Osada, Shigehiro

AU - Nishihara, Tsutomu

AU - Imagawa, Masayoshi

PY - 2000

Y1 - 2000

N2 - CCAAT/enhancer-binding protein δ (C/EBPδ) transcription factor is rapidly induced at an early stage of acute phase response. We previously reported that this induction was mainly mediated by acute phase response factor/signal transducers and activators of transcription 3 (APRF/STAT3). Furthermore, the high expression level of C/EBPδ is maintained by autoregulation mechanisms through the C/EBPδ binding sites located downstream of C/EBPδ gene. Thereafter, the expression of C/EBPδ gene decreases rapidly to the basal level. However, these mechanisms are still unknown. According to both transfection and DNA binding analyses, liver-enriched inhibitory protein (LIP), the shorter form of C/EBPβ and C/EBP-homologous protein 10 (CHOP10), were found to inhibit C/EBPδ gene expression. DNA binding analysis has further indicated that both LIP and CHOP10 form heterodimers with C/EBPδ, and inhibit the binding of C/EBPδ homodimer to the C/EBPδ binding sites located downstream of C/EBPδ gene. Taken together, these findings indicated that the maintained expression of C/EBPδ gene by autoregulation was inhibited and decreased to the basal level as a result of the competition of other C/EBP family proteins. Thus, C/EBPδ gene expression is mediated by the gene regulation circuit through the downstream C/EBPδ binding sites.

AB - CCAAT/enhancer-binding protein δ (C/EBPδ) transcription factor is rapidly induced at an early stage of acute phase response. We previously reported that this induction was mainly mediated by acute phase response factor/signal transducers and activators of transcription 3 (APRF/STAT3). Furthermore, the high expression level of C/EBPδ is maintained by autoregulation mechanisms through the C/EBPδ binding sites located downstream of C/EBPδ gene. Thereafter, the expression of C/EBPδ gene decreases rapidly to the basal level. However, these mechanisms are still unknown. According to both transfection and DNA binding analyses, liver-enriched inhibitory protein (LIP), the shorter form of C/EBPβ and C/EBP-homologous protein 10 (CHOP10), were found to inhibit C/EBPδ gene expression. DNA binding analysis has further indicated that both LIP and CHOP10 form heterodimers with C/EBPδ, and inhibit the binding of C/EBPδ homodimer to the C/EBPδ binding sites located downstream of C/EBPδ gene. Taken together, these findings indicated that the maintained expression of C/EBPδ gene by autoregulation was inhibited and decreased to the basal level as a result of the competition of other C/EBP family proteins. Thus, C/EBPδ gene expression is mediated by the gene regulation circuit through the downstream C/EBPδ binding sites.

KW - Autoregulation

KW - CCAAT/enhancer-binding protein

KW - CHOP

KW - Gene expression

KW - Trans-acting factor

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=0034536688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034536688&partnerID=8YFLogxK

M3 - Article

C2 - 11145170

AN - SCOPUS:0034536688

VL - 23

SP - 1424

EP - 1429

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 12

ER -